The prevalence of CYP2C8, 2C9, 2J2, and soluble epoxide hydrolase polymorphisms in African Americans with hypertension

American Journal of Hypertension

Volumn 18, Issue 10, 2005, Pages 1276-1281

  Dreisbach, Albert W ^a   Japa, Shanker ^a   Sigel, Aster ^a   Parenti, Melissa B ^a   Hess, Arthur E ^a   Srinouanprachanh, Sengkeo L ^b   Rettie, Allan E ^c   Kim, Helen ^b   Farin, Federico M ^b   Hamm, L Lee ^a   Lertora, Juan J L ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

African American; Cytochrome P450; Genetic polymorphisms; Hypertension; Soluble epoxide hydrolase

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 2C8; CYTOCHROME P450 2C9; CYTOCHROME P450 2J2; EPOXIDE HYDROLASE; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ALLELE; ARTICLE; BLOOD SAMPLING; CASE CONTROL STUDY; CONTROLLED STUDY; DNA EXTRACTION; ENZYME ACTIVITY; ENZYME POLYMORPHISM; ETHNIC GROUP; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; VENOUS BLOOD;

ADULT; AFRICAN AMERICANS; ALLELES; ARYL HYDROCARBON HYDROXYLASES; CASE-CONTROL STUDIES; CYTOCHROME P-450 ENZYME SYSTEM; EPOXIDE HYDROLASES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; HYPERTENSION; LINKAGE DISEQUILIBRIUM; LOUISIANA; MALE; MIDDLE AGED; OXYGENASES; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; RISK FACTORS; UNITED STATES;

EID: 25844438367     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2005.04.019     Document Type: Article

References (32)

1. K. Omata, K. Abe, H.-L. Sheu, K. Yoshida, E. Tsutsumi, K. Yoshinaga, N.G. Abraham, M. Laniado-Shwartzman Roles of renal cytochrome P450-dependent ararchidonic acid metabolites in hypertension Tohoku J Exp Med 166 1992 93 106
2. M. Rahman, J.T. Wright, J.G. Douglas The role of cytochrome P450-dependent Metabolites of arachidonic acid in blood pressure regulation and renal function Am J Hypertens 10 1997 356 365
3. K. Makita, J.R. Falck, J.H. Capdevila Cytochrome P450, the arachidonic acid cascade, and hypertension new vistas for an old enzyme system FASEB J 10 1996 1456 1463
4. J.H. Capdevila, J.R. Falck, R.C. Harris Cytochrome P450 and arachidonic acid bioactivation molecular and functional properties of arachidonate mono-oxygenase J Lipid Res 41 2000 163 181
5. R.J. Roman P-450 metabolites of arachidonic acid in the control of cardiovascular function Physiol Rev 82 2002 131 185
6. I. Fleming, U.R. Michaelis, D. Bredenkotter, B. Fisslthaler, F. Dehghani, R.P. Brandes, R. Busse Endothelium-derived hyperpolarizing factor synthase (cytochrome P450 2C9) is a functionally significant source of reactive oxygen species in coronary arteries Circ Res 88 2001 44 51
7. 2+changes and dilation in isolated resistance arteries FASEB J 14 2000 255 260
8. J. Quilley, J.C. McGiff Is EDHF an epoxyeicosatrienoic acid? Trends Pharmacol Sci 21 2000 121 124
9. B. Fisslthlaler, N. Hinsch, T. Chataigneau, R. Popp, L. Kiss, R. Busse, I. Fleming Nifedipine increases cyotchrome P4502C expression and endothelium-derived-hyperpolarizing factor-mediated responses in coronary arteries Hypertension 36 2000 270 275
10. V.R. Holla, K. Makita, P.G. Zaphiropoulos, J.H. Capdevila The kidney cytochrome P450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading J Clin Invest 104 1999 751 760
11. F. Catella, J.A. Lawson, D.J. Fitzgerald, G.A. Fitzgerald Endogenous biosynthesis of arachidonic acid epoxides in humans increased formation in pregnancy-induced hypertension Proc Natl Acad Sci 87 1990 5893 5897
12. Z. Yu, L.M. Huse, P. Adler, L. Graham, J. Ma, D.C. Zeldin, D.L. Kroetz Increased CYP2CJ expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney Mol Pharmacol 57 2000 1011 1020
13. C. Moreno, K.G. Maier, K.M. Hoagland, M. Yu, R.J. Roman Abnormal pressure-natriuresis in hypertension role of cytochrome P450 metabolites of arachidonic acid Am J Hypertens 14 2001 90S 97S
14. J. Chen, J.H. Capdevila, D.C. Zeldin, R.L. Rosenberg Inhibition of cardiac L-type calcium channels by epoxyeicosatrienoic acids Mol Pharm 55 1999 288 295
15. T.H. Sullivan-Klose, B.I. Ghanayem, D.A. Bell, Z.Y. Zhang, L.S. Kaminsky, G.M. Shenfield, J.O. Miners, D.J. Birkett, J.A. Goldstein The role of CYP2C9-Leu 359 allelic variant in the tolbutamide polymorphism Pharmacogenetics 6 1996 341 349
16. A.E. Rettie, L.C. Wienkers, F.J. Gonzalez, W.F. Trager, K.R. Korzekwa Impaired (S)-warfarin metabolism catalyzed by the R144C allelic variant of CYP2C9 Pharmacogenetics 4 1994 39 42
17. D. Dai, D.C. Zeldin, J.A. Blaisdell, B. Chanas, S.J. Coulter, B.I. Ghanayem, J.A. Goldstein Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid Pharmacogenetics 11 2001 597 607
18. M. Sandberg, C. Hassett, E.T. Adman, J. Meijer, C.J. Omiecinski Identification and functional characterization of human soluble epoxide hydrolase genetic polymorphisms J Biol Chem 275 2000 28873 28881
19. L.M. King, J. Ma, S. Srettabunjong, J. Graves, J.A. Bradbury, L. Li, M. Speicker, J.K. Liao, H. Morhrenweiser, D.C. Zeldin Cloning of CYP2J2 gene and identification of functional polymorphisms Mol Pharmacol 61 2002 840 852
20. M.K. Higashi, D.L. Veenstra, L.M. Kondo, A.K. Wittkowsky, S.L. Srinouanprachanh, F.M. Farin, A.E. Rettie Association between CYP2C9 genetic variants and anticoagulation-related outcomes during warfarin therapy J Am Med Assoc 287 2002 1690 1698
21. L. Excoffier, M. Slatkin Maximum-likelihood estimation of molecular haplotype frequencies in a diploid population Mol Biol Evol 12 1995 921 927
22. J.K. Pritchard, M. Przeworski Linkage disequilibrium in humans model and data Am J Hum Genet 69 2001 1 14
23. C.L. Laffer, M. Laniado-Shwartzman, M.H. Wang, A. Nasjletti, F. Elijovich Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic acid in human salt-sensitive versus salt-resistant hypertension Circulation 107 2003 574 578
24. X. Zhao, T. Yamamoto, J.W. Newman, I.H. Kim, T. Watanabe, B.D. Hammock, J. Stewart, J.S. Pollock, D.M. Pollock, J.D. Imig Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage J Am Soc Nephrol 15 2004 1244 1253
25. E. Kaergel, D.N. Muller, H. Honeck, J. Theuer, E. Shagdarsuren, A. Mullally, F.C. Luft, W.H. Shunck P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage Hypertension 40 2002 273 279
26. X. Zhao, D.M. Pollock, E.W. Inscho, D.C. Zeldin, J.D. Imig Decreased cytochrome P450 2C enzymes and impaired vasodilation are associated with angiotensin induced salt sensitive hypertension Hypertension 41 2003 709 714
27. V.R. Holla, K. Makita, P.G. Zaphiropoulos, J.H. Capdevila The kidney cytochrome P-450 2C23 arachidonic acid epoxygenase is upregulated during dietary salt loading J Clin Invest 104 1999 751 760
28. M.L. Schwartzman, N.R. Ferreri, M.A. Carroll, E. Songue-Mize, J.C. McGiff Renal cytochrome P450-related arachidonate metabolites inhibits (Na+ + K +) ATPase Nature 314 1985 620 622
29. R.J. Romero, Z.T. Madhun, U. Hooper, J.G. Douglas An epoxygenase metabolite of arachidonic acid 5,6 epoxy-eicosatrienoic acid mediates angiotensin-induced natruiresis in proximal tubular epithelium Adv Prostaglandin Thromboxane Leukot Res 21A 1991 205 208
30. C.J. Sinal, M. Miyata, M. Tohkin, K. Nagata, J.R. Bend, F.J. Gonzalez Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation J Biol Chem 275 2000 40504 40510
31. L.M. King, J.V. Gainer, David, L. Gloria, D. Dai, J.A. Goldstein, N.J. Brown, D.C. Zeldin Single nucleotide polymorphisms in the CYP2J2 and CYP2C8 genes and the risk of hypertension Pharmacogenet Genom 15 2005 7 13
32. U. Yasar, S. Lundgren, E. Eliasson, A. Bennet, B. Wiman, U. de Faire, A. Rane Linkage between the CYP2C8 and CYP2C9 genetic polymorphisms Biochem Biophys Res Commun 299 2002 25 28